Zenas BioPharma Market Sentiment

SPY749.50−1.01%QQQ674.07−2.05%BTC/USD68,552.90−3.95%DIA520.80−0.32%GLD355.57+0.19%TLT79.50−0.28%

Premium Services

Zenas BioPharma Inc

ZBIONASDAQ

Trade with Public

$27.64

0.0050.02%

Last update: Nov 13, 11:49 AM

Overview News Charts Earnings Forecast Events Price Targets FinancialsSentimentOwnership Dividends Compare Options Stock Report

Zenas BioPharma Market Sentiment

Market sentiment signals for Zenas BioPharma (ZBIO): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 25.6% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

9 analysts

Options Flow (P/C)

—

0 calls · 1 puts

Avg Consensus PT

$41

+47.5%

Highest Price Target

$55

+99.0%

Evercore ISI Group

Lowest Price Target

$19

-31.3%

Wolfe Research

Short Interest

25.6%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 13, 2026	HC Wainwright & Co.	Matthew Caufield—	+59.2%	$44 → $44	Maintained	Buy
Sep 30, 2026	Citigroup	Yigal Nochomovitz—	+73.6%	$41 → $48	Maintained	Buy
Sep 30, 2026	Wedbush	Martin Fan —	+62.8%	$45 → $45	Maintained	Outperform
Sep 30, 2026	HC Wainwright & Co.	Matthew Caufield—	+59.2%	$44 → $44	Maintained	Buy
Aug 14, 2026	Morgan Stanley	Judah Frommer—	+15.8%	$22 → $32	Maintained	Equal-Weight
Aug 14, 2026	Guggenheim	Yatin Suneja—	+99.0%	$55 → $55	Maintained	Buy
Aug 14, 2026	Wedbush	Martin Fan —	+62.8%	$45 → $45	Maintained	Outperform
May 15, 2026	HC Wainwright & Co.	Matthew Caufield—	+59.2%	$44 → $44	Maintained	Buy
May 14, 2026	Morgan Stanley	Judah Frommer—	-20.4%	$21 → $22	Maintained	Equal-Weight
Mar 17, 2026	Citigroup	Yigal Nochomovitz—	+48.3%	$43 → $41	Maintained	Buy
Mar 17, 2026	Guggenheim	Yatin Suneja—	+99.0%	$45 → $55	Maintained	Buy
Mar 17, 2026	Morgan Stanley	Judah Frommer—	-24.0%	$19 → $21	Maintained	Equal-Weight
Mar 17, 2026	HC Wainwright & Co.	Matthew Caufield—	+59.2%	$44 → $44	Maintained	Buy
Feb 10, 2026	HC Wainwright & Co.	Matthew Caufield—	+59.2%	$44 → $44	Maintained	Buy
Jan 6, 2026	Morgan Stanley	Judah Frommer—	-31.3%	$37 → $19	Downgrade	Overweight→Equal-Weight
Dec 22, 2025	Wedbush	Martin Fan —	+62.8%	$45 → $45	Maintained	Outperform
Nov 26, 2025	Evercore ISI Group	Cory Kasimov—	+99.0%	$55	Initiate	Outperform
Nov 13, 2025	Morgan Stanley	Judah Frommer—	+33.8%	$34 → $37	Maintained	Overweight
Oct 28, 2025	Citigroup	Yigal Nochomovitz—	+66.4%	$27 → $46	Maintained	Buy
Oct 28, 2025	Morgan Stanley	Vikram Purohit—	+23.0%	$31 → $34	Maintained	Overweight
Oct 28, 2025	HC Wainwright & Co.	Matthew Caufield—	+59.2%	$30 → $44	Maintained	Buy
Oct 9, 2025	Wedbush	Martin Fan —	+44.7%	$35 → $40	Maintained	Outperform
Oct 9, 2025	HC Wainwright & Co.	Matthew Caufield—	+8.5%	$30 → $30	Maintained	Buy
May 16, 2025	HC Wainwright & Co.	Matthew Caufield—	+8.5%	$30 → $30	Maintained	Buy
Mar 20, 2025	Wedbush	Martin Fan —	+26.6%	$35	Initiate	Outperform

Zenas BioPharma Inc

Zenas BioPharma Market Sentiment

Key Signals

Recent Analyst Actions

Zenas BioPharma Market Sentiment

Bulls vs Bears

Key Signals

Recent Analyst Actions

People Also Watch

Bulls vs Bears

People Also Watch